Novel Strategies of Localized Drug Delivery to Re-Think the Application of JAK inhibitors

Time: 1:45 pm
day: Day Two


  • Developing a biocompatible lipid nanoformulation that encapsulate JAK inhibitors to achieve preferential targeting of the gut immune system following oral administration.
  • Exploring a novel potential for JAK inhibitors as immunotherapeutics, rather than immunosuppressive drugs, in the treatment of autoimmunity and transplant rejection.
  • Developing injectable hydrogels for localized and controlled release of JAK inhibitors and future advances.